Kopran
KOPRAN · Pharma > Pharmaceuticals & Drugs · Chairman: Susheel G Somani Listing date: Nov. 26, 1994 · Employees: 348 · Mumbai · http://www.kopran.com

Stock Price vs Company Growth
1d
3.7%
1w
11.6%
1m
29.9%
3m
34.9%
6m
15.2%
1y
25.2%
5y
43.6%
10y
13.6%
all
10.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 200 3.7%
198
369
Company Overview

Sales
636 Cr
Growth: 14.0%
Profit after Tax
52.9 Cr
Growth: -10.8%
Small Cap
963 Cr
P/E: 18.2x
Industry P/E: 35.6x
Fundamentals

Sales (Cr) ₹ 636
Growth 14.0%
EBITDA 12.3%
P/S 1.5x
Dividend 1.2%
P/E 18.2x
Book Value ₹ 106
PEG Ratio 1.3x
ROE 10.7%
P/B 1.9x
Shareholding Pattern

Institutions
Rikeen Pradip Dalal
1.24 %
Promoters
Oricon Enterprises Limited
13.91 %
Panorama Finvest Pvt.Ltd.
8.79 %
Sarvamangal Mercantile Co.Ltd.
6.71 %
Rajendra Somani
5.37 %
Susheel Somani
2.02 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company was incorporated on April 26, 1958 as a private limited company under the name Kopran Chemical Company Pvt. Ltd. by Ramanlal V Shah Sevantilal, A Shah , Chimanlal G Sheth and Jivanalal M Shah. In 1972, the company’s management was acquired by Chemo Pharma Laboratories Ltd and the Company’s products were marketed by them.Promoted by the Parijat Enterprises, Kopran is currently an integrated health care company.
Investors (62)
Followers (3)